CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present a company overview at the Canaccord Genuity 36th Annual Growth Conference on Wednesday, August 10, 2016 at 11:00 a.m. ET at the InterContinental Boston.
